Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 Rita Xu + 685 word(s) 685 2020-12-15 07:36:00

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Xu, R. Progressive Supranuclear Palsy. Encyclopedia. Available online: https://encyclopedia.pub/entry/5486 (accessed on 25 September 2026).
Xu R. Progressive Supranuclear Palsy. Encyclopedia. Available at: https://encyclopedia.pub/entry/5486. Accessed September 25, 2026.
Xu, Rita. "Progressive Supranuclear Palsy" Encyclopedia, https://encyclopedia.pub/entry/5486 (accessed September 25, 2026).
Xu, R. (2020, December 24). Progressive Supranuclear Palsy. In Encyclopedia. https://encyclopedia.pub/entry/5486
Xu, Rita. "Progressive Supranuclear Palsy." Encyclopedia. Web. 24 December, 2020.
Progressive Supranuclear Palsy
Edit

Progressive supranuclear palsy is a brain disorder that affects movement, vision, speech, and thinking ability (cognition). The signs and symptoms of this disorder usually become apparent in mid- to late adulthood, most often in a person's 60s. Most people with progressive supranuclear palsy survive 5 to 9 years after the disease first appears, although a few affected individuals have lived for more than a decade.

genetic conditions

References

  1. Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wiederholt W, Hansen L, Masliah E, Thal LJ, Katzman R, Xia Y, Saitoh T. Genetic evidence forthe involvement of tau in progressive supranuclear palsy. Ann Neurol. 1997Feb;41(2):277-81.
  2. Donker Kaat L, Boon AJ, Azmani A, Kamphorst W, Breteler MM, Anar B, Heutink P,van Swieten JC. Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology. 2009 Jul 14;73(2):98-105. doi: 10.1212/WNL.0b013e3181a92bcc.
  3. Ferrari R, Ryten M, Simone R, Trabzuni D, Nicolaou N, Hondhamuni G, RamasamyA, Vandrovcova J; UK Brain Expression Consortium, Weale ME, Lees AJ, Momeni P,Hardy J, de Silva R. Assessment of common variability and expression quantitativetrait loci for genome-wide associations for progressive supranuclear palsy.Neurobiol Aging. 2014 Jun;35(6):1514.e1-12. doi:10.1016/j.neurobiolaging.2014.01.010.Aging. 2015 Nov;36(11):3118. Nicolaou, Naiya [Corrected to Nicolaou, Nayia].Neurobiol Aging. 2015 Nov;36(11):3118.
  4. Golbe LI. Progressive supranuclear palsy. Semin Neurol. 2014 Apr;34(2):151-9. doi: 10.1055/s-0034-1381736.
  5. Höglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, RademakersR, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, UittiRJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, BorroniB, Pastor P; PSP Genetics Study Group, Cantwell LB, Han MR, Dillman A, van derBrug MP, Gibbs JR, Cookson MR, Hernandez DG, Singleton AB, Farrer MJ, Yu CE,Golbe LI, Revesz T, Hardy J, Lees AJ, Devlin B, Hakonarson H, Müller U,Schellenberg GD. Identification of common variants influencing risk of thetauopathy progressive supranuclear palsy. Nat Genet. 2011 Jun 19;43(7):699-705.doi: 10.1038/ng.859.
  6. Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL,Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, AdlerC, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ,Graff-Radford N, Litvan I, Farrer MJ, Dickson DW, Hutton M, Stephan DA.Identification of a novel risk locus for progressive supranuclear palsy by apooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J HumGenet. 2007 Apr;80(4):769-78.
  7. Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathologicalconcepts and diagnostic challenges. Lancet Neurol. 2009 Mar;8(3):270-9. doi:10.1016/S1474-4422(09)70042-0. Review.
More
Upload a video for this entry
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : Rita Xu
View Times: 1.1K
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020
Notice
You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
OK
Confirm
Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
Yes
No
${ textCharacter }/${ maxCharacter }
Submit
Cancel
There is no comment~
${ textCharacter }/${ maxCharacter }
Submit
Cancel
${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
Submit
Cancel
Confirm
Are you sure to Delete?
Yes No
Academic Video Service